Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurine Supplementation in Adolescents With Post-COVID Condition
NCT07682402Phase 2Not yet recruiting
- Sponsor
- University of Alberta
- Start
- Dec 2026
- Primary completion
- Mar 2028
01
Overview
Phase 2, open-label, single-arm trial of taurine in post-COVID-19 condition (PCC), sponsored by University of Alberta. Primary endpoint: Mean Change in Plasma Taurine Levels at 3 months. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
taurine
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT07682402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07682402.